HFA Premium Access

Panel discussion and close - Management of hyperkalaemia in patients with heart failure – Overcoming barriers to optimal renin-angiotensin-aldosterone system inhibitor therapy.

Topic: Comorbidities
Organised by MedEd Global Solutions & University of Lorraine, supported with an educational grant from Vifor Pharma

Congress Presentation

About the speaker

Professor Javed Butler

Baylor Scott and White Health, Dallas (United States of America)
105 presentations
14 followers

4 more presentations in this session

Welcome and introduction - Management of hyperkalaemia in patients with heart failure – Overcoming barriers to optimal renin-angiotensin-aldosterone system inhibitor therapy.

Speaker: Professor F. Zannad (Vandoeuvre-Les-Nancy, FR)

Thumbnail

Hyperkalaemia in patients with heart failure – Addressing the unmet medical need.

Speaker: Professor M. Lainscak (Murska Sobota, SI)

Thumbnail

New evidence on hyperkalaemia management in patients with heart failure, resistant hypertension and chronic kidney disease – The cardiologist’s perspective.

Speaker: Professor I. Pina (Philadelphia, US)

Thumbnail

New evidence on hyperkalaemia management in patients with heart failure, resistant hypertension and chronic kidney disease – The nephrologist’s perspective.

Speaker: Professor P. Rossignol (Monaco, MC)

Thumbnail

Access the full session

Management of hyperkalaemia in patients with heart failure – Overcoming barriers to optimal renin-angiotensin-aldosterone system inhibitor therapy

Speakers: Professor J. Butler, Professor F. Zannad, Professor M. Lainscak, Professor I. Pina, Professor P. Rossignol
Thumbnail

About the event

Image

Heart Failure 2019

25 May - 28 May 2019

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb